Our analysis found that HCPs reacted as positively to the other two most-discussed lung cancer trials at ASCO 2024 - ADRIATIC ...

In the language of immuno-oncology (IO), the terms “hot” and “cold” refer to tumours that are inflamed or non-inflamed, ...

As Phil Taylor reported, this morning, the Association of the British Pharmaceutical Industry (ABPI) released its comments on ...

Researchers from Harvard and Brigham and Women’s Hospital in Boston found an elevated risk with semaglutide of a condition ...

Boehringer filed its challenge last August after it became clear that its big-selling diabetes treatment Jardiance ...

Just like people, no two cancer cells are alike. And now, scientists from the University of Surrey and SCIEX have come ...

This time last year, Pieris also lost a partnership with AstraZeneca on respiratory drug candidate elarekibep, one of up to ...

About Aktiia - A vehicle for discovery in blood pressure Aktiia was founded in Switzerland in May 2018 from a passion to ...

While the headlines are all about the Labour landslide in the UK general election this morning, Wes Streeting, who has been ...

The Series B – led by Forbion and joined by other investors, including Syncona, Oxford Science Enterprises, and Oxford ...

NeuroSense said that ALSFRS-R is the current “gold-standard” scale used in ALS drug development and the new data highlights ...

GSK has upgraded its longstanding alliance with CureVac on mRNA-based vaccines for respiratory infections, paying €400 ...